Go here to read the rest:
Lotus Ventures Inc. Reports Fiscal 2021 Results

Read more here:
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform

Originally posted here:
Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences

See the original post:
Chinook Therapeutics to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 58th ERA-EDTA Congress

Read more from the original source:
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more from the original source:
OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19...

Read this article:
Pluristem Announces Uplisting to the Nasdaq Global Market®

Excerpt from:
Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands

See the rest here:
GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary General Meeting of January 13, 2021

Go here to read the rest:
Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer

See the original post here:
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in...

Read the original here:
ImmuCell Announces Restructuring of its Bank Debt

Read the original here:
Transactions in connection with share buyback program

More here:
Operational and Financial Results for the Period Ended September 30, 2020

See the rest here:
Mesoblast Corporate Update and Financial Results Webcast

Read this article:
Burning Rock Reports Third Quarter 2020 Financial Results

Read more from the original source:
Obalon Announces Third Quarter 2020 Financial Results

Link:
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results

Link:
Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review...

View post:
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program